What do you think about this?

A small percentage of women, less than 4%, would benefit from this treatment whilst hundreds of others are exposed to the risk of side effects. In addition, there will be a significant cost to the NHS for providing this medication to all of those women.

It is a very difficult job to balance the risks, costs and benefits of treatments such as these and undoubtedly there will be people who feel strongly on both sides of the debate.